The Osteoarthritis Treatment Market was valued at USD 4,999.98 million in 2018 and is predicted to reach USD 8,555.44 million in 2026, representing a CAGR of 9 percent over the forecast period.
The COVID-19 pandemic is predicted to have a short-term influence on the market growth under consideration. According to a study published in the Clinical Pharmacology and Therapeutics Journal in May 2020 by Enrico Ragni et al., the presence of osteoarthritis-related concurrent disorders is likely to commence life-threatening hazards for osteoarthritis patients in the event of SARS-CoV2 virus infection.
This has prompted clinicians and orthopedists to carefully check and evaluate osteoarthritis patients, not just for symptom management but also for comorbidities that may arise as a result of osteoarthritis treatment during the COVID19 pandemic. As a result of the aforementioned causes, the market under study is projected to be impacted during the current pandemic era.
Read more @ https://cmilatestinsights.blogspot.com/2021/12/osteoarthritis-treatment-market-global.html
